Declaration of equity dividend for the FY 2024-25.
SICAGEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sicagen India's board, at its meeting on May 12, 2025, approved the audited financial results (standalone and consolidated) for Q4 and FY ended March 31, 2025. The board recommended an equity dividend of 10% (Re.1 per share) for FY 2024-25, pending shareholder approval at the 21st AGM. The auditor's report carries an unmodified opinion on the financial results. Additionally, M/s. KRA & Associates were appointed as Secretarial Auditors for a 5-year term (FY 2025-26 to FY 2029-30), while M/s. Sundar Srini & Sridhar and M/s. Karthikeyan & Associates were re-appointed as Internal Auditors and Cost Auditor, respectively, for FY 2025-26.
The 10% dividend signals steady returns for shareholders, while the clean (unmodified) auditor opinion reinforces confidence in the company's financial reporting. No material changes in auditor positions beyond routine appointments.